Advertisement

Ads Placeholder
Loading...

Sera Prognostics, Inc.

SERANASDAQ
Healthcare
Medical - Diagnostics & Research
$2.01
$-0.06(-2.90%)
U.S. Market opens in 19h 49m

Sera Prognostics, Inc. Fundamental Analysis

Sera Prognostics, Inc. (SERA) shows weak financial fundamentals with a PE ratio of -3.15, profit margin of -394.17%, and ROE of -37.50%. The company generates $0.0B in annual revenue with weak year-over-year growth of -74.84%.

Key Strengths

Cash Position39.02%
PEG Ratio-0.27
Current Ratio1.69

Areas of Concern

ROE-37.50%
Operating Margin-450.67%
We analyze SERA's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -29648.0/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-29648.0/100

We analyze SERA's fundamental strength across five key dimensions:

Efficiency Score

Weak

SERA struggles to generate sufficient returns from assets.

ROA > 10%
-31.32%

Valuation Score

Excellent

SERA trades at attractive valuation levels.

PE < 25
-3.15
PEG Ratio < 2
-0.27

Growth Score

Moderate

SERA shows steady but slowing expansion.

Revenue Growth > 5%
-74.84%
EPS Growth > 10%
14.66%

Financial Health Score

Excellent

SERA maintains a strong and stable balance sheet.

Debt/Equity < 1
0.03
Current Ratio > 1
1.69

Profitability Score

Weak

SERA struggles to sustain strong margins.

ROE > 15%
-3749.63%
Net Margin ≥ 15%
-394.17%
Positive Free Cash Flow
No

Key Financial Metrics

Is SERA Expensive or Cheap?

P/E Ratio

SERA trades at -3.15 times earnings. This suggests potential undervaluation.

-3.15

PEG Ratio

When adjusting for growth, SERA's PEG of -0.27 indicates potential undervaluation.

-0.27

Price to Book

The market values Sera Prognostics, Inc. at 1.33 times its book value. This may indicate undervaluation.

1.33

EV/EBITDA

Enterprise value stands at -2.20 times EBITDA. This is generally considered low.

-2.20

How Well Does SERA Make Money?

Net Profit Margin

For every $100 in sales, Sera Prognostics, Inc. keeps $-394.17 as profit after all expenses.

-394.17%

Operating Margin

Core operations generate -450.67 in profit for every $100 in revenue, before interest and taxes.

-450.67%

ROE

Management delivers $-37.50 in profit for every $100 of shareholder equity.

-37.50%

ROA

Sera Prognostics, Inc. generates $-31.32 in profit for every $100 in assets, demonstrating efficient asset deployment.

-31.32%

Following the Money - Real Cash Generation

Operating Cash Flow

Sera Prognostics, Inc. generates limited operating cash flow of $-19.57M, signaling weaker underlying cash strength.

$-19.57M

Free Cash Flow

Sera Prognostics, Inc. generates weak or negative free cash flow of $-20.13M, restricting financial flexibility.

$-20.13M

FCF Per Share

Each share generates $-0.53 in free cash annually.

$-0.53

FCF Yield

SERA converts -34.34% of its market value into free cash.

-34.34%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-3.15

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.27

vs 25 benchmark

P/B Ratio

Price to book value ratio

1.33

vs 25 benchmark

P/S Ratio

Price to sales ratio

947.33

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.03

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.69

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.37

vs 25 benchmark

ROA

Return on assets percentage

-0.31

vs 25 benchmark

ROCE

Return on capital employed

-0.47

vs 25 benchmark

How SERA Stacks Against Its Sector Peers

MetricSERA ValueSector AveragePerformance
P/E Ratio-3.1528.45 Better (Cheaper)
ROE-37.50%763.00% Weak
Net Margin-39417.28%-45265.00% (disorted) Weak
Debt/Equity0.030.34 Strong (Low Leverage)
Current Ratio1.692795.60 Neutral
ROA-31.32%-16588.00% (disorted) Weak

SERA outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Sera Prognostics, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

16.81%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

12.10%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

59.90%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ